Table 2.
Clinical trials
| NCT ID | Drugs |
|---|---|
| 00417807 | Imatinib mesylate |
| 01189643 | Iriontecan, temozolomide, bevacizumab incorporated into an existing schedule of high dose alkylator. |
| 00563680 | AMG-479 |
| 00055952 | Exatecan mesylate |
| 01277744 | Hyperthermic peritoneal perfusion with cisplatin. |
| 01099644 | Radioimmunotherapy. |
| 00062205 | Imatinib mesylate |
| 00436657 | Hyperthermic perfusion with cisplatin. |
| 01287104 | NK cell infusion following allogeneic stem cell transplantation. |
| 01125449 | Ascorbic acid (vitamin C) |
| 00445965 | Iodine I131 monoclonal antibody 3F8. |
| 00720174 | IMC-A12, doxorubicine hydrochloride. |
| 00003926 | Amifostine to protect form side effects of PSCT. |
| 00002515 | Chemotherapy in combination with bone marrow transplantation. |
| 00024258 | Arsenic trioxide. |
| 00043979 | Stem cell transplantation. |
| 00562380 | AMG-479. |
| 01154452 | GDC-0449 and RO4929097. |
| 00025441 | Combination chemotherapy. |
| 00794521 | Pazopanib. |
| 00474994 | Sunitinib malate |
| 00526149 | BI 2536 |
| 00002466 | Combination chemotherapy and radiation therapy. |
| 00030667 | Imatinib mesylate. |
| 00089245 | Iodine I131 monoclonal antibody 8H9. |
| 00093821 | Tanespimycin |
| 00662233 | Combination chemotherapy |
| 00002898 | Surgery followed by chemotherapy. |
| 01189253 | Doxorubicin or Trabectedin. |